Farnum Rhonda (CIK 0001898490)

Latest company ownership

Role: SVP, COMM & MEDICAL AFFAIRS
Shares held
308,762
Last filed at
Dec 5, 2025
Confidence Score
21.4
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 3, 2025 Dec 5, 2025 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 22.5 -31,067 -10.06% $582.5K
Nov 20, 2025 Nov 24, 2025 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -9,060 -2.85% $162.2K
Aug 20, 2025 Aug 22, 2025 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -9,096 -2.78% $121.8K
Jul 14, 2025 Jul 16, 2025 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 41.3 -10,000 -2.97% $113.9K
Jun 2, 2025 Jun 4, 2025 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 30.0 -24,000 -6.65% $264K
May 20, 2025 May 22, 2025 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -9,120 -2.46% $86.2K
Apr 21, 2025 Apr 23, 2025 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 48.8 -4,000 -1.07% $36K
Feb 10, 2025 Feb 24, 2025 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -10,527 -3.40% $152.7K
Jan 21, 2025 Jan 23, 2025 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 48.8 -4,000 -1.28% $36K
Nov 20, 2024 Nov 22, 2024 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -9,178 -2.84% $91.5K
Nov 11, 2024 Nov 13, 2024 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 48.8 -4,000 -1.22% $36K
Aug 20, 2024 Aug 22, 2024 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -9,222 -2.74% $75.8K
Jul 10, 2024 Jul 12, 2024 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 48.8 -4,000 -1.18% $36K
May 20, 2024 May 22, 2024 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -9,268 -2.65% $84.3K
Feb 20, 2024 Feb 22, 2024 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 32.5 -19,473 -5.88% $173.4K
Nov 20, 2023 Nov 22, 2023 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 41.3 -9,360 -2.75% $97K
Aug 22, 2023 Aug 24, 2023 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 51.3 -1,807 -0.53% $17.1K
Aug 20, 2023 Aug 22, 2023 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -10,460 -2.96% $101.5K
Jun 8, 2023 Jun 12, 2023 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 51.3 -1,790 -0.50% $19.9K
May 20, 2023 May 23, 2023 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -5,567 -1.55% $62.4K
Mar 9, 2023 Mar 13, 2023 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 26.3 -4,000 -1.10% $40.8K
Feb 20, 2023 Feb 22, 2023 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -7,119 -2.40% $74.3K
Nov 20, 2022 Nov 22, 2022 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 40.0 -23,268 -7.28% $252.5K
Aug 19, 2022 Aug 23, 2022 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -10,413 -3.16% $97.3K
May 20, 2022 May 24, 2022 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 51.3 -3,281 -0.98% $28.9K
Feb 28, 2022 Mar 2, 2022 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 51.3 -2,356 -0.70% $23.9K
Feb 18, 2022 Feb 23, 2022 Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS Sell 42.5 -11,824 -3.40% $113.6K